investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity
Karin Alexandra Skalina
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Karin Alexandra Skalina
Albert Einstein College of Medicine
Bronx, United States
Related projects
Towia A Libermann
Role of Axl in docetaxel resistance in prostate cancer
Prostate
Pathology
Tina Hernandez-Boussard
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
Prostate
Nora Navone
Modeling Prostate Cancer Bone Metastasis in the Mouse-basic Biology and Translational Impact
Prostate
Tony R Hunter
Signal Transduction by Tyrosine Phosphorylation
Prostate
Bruce R Zetter
Modulators of Prostate Cancer Metastasis
Prostate
Jeffrey Green
Transgenic Models for Prostate and Breast Cancer
Prostate
Dhyan Chandra
Hsp60 regulation of apoptosis in prostate cancer
Prostate
Jeffrey Gildersleeve
Serum Antibody Profiling with a Carbohydrate Microarray
Prostate
Pathology
Hans Lilja
Prospective validation of a multi-marker prostate cancer prediction model
Prostate